title: Clinical outcomes of a furosemide infusion protocol in edematous patients in the intensive care unit.
abstract: BACKGROUND
  Many critically ill patients have severe volume overload due to vigorous fluid resuscitation. Optimal fluid management strategies to clear tissue edema are unclear.
  
  
  OBJECTIVE
  To assess safety and effectiveness of a clinical application of a furosemide infusion protocol in edematous critically ill patients.
  
  
  METHODS
  A prospective, cohort study of consecutive adult critically ill patients who received furosemide infusion by protocol from June 2003 to July 2004.
  
  
  RESULTS
  The mean total dose of furosemide was 2240 mg. The mean cumulative fluid balance therapy was -3376 mL. Electrolyte values in the critical laboratory range were 3.3% for potassium, 0.2% for sodium, and no critical values for magnesium. The mean change in creatinine level was +0.2 mg/dL during furosemide infusion therapy, but the mean creatinine level returned to baseline by 3 days after the furosemide infusion. A minimum mean arterial pressure less than 55 mm Hg occurred 12% of the time during the furosemide infusion.
  
  
  CONCLUSIONS
  Furosemide infusion therapy was associated with moderately negative cumulative fluid balances, electrolyte shifts, and mild transient worsening of renal function.
authors.affiliation: Coronary Intensive Care Unit, Intermountain Medical Center in Murray, Utah 84107, USA.
authors.forename: George
authors.initials: G
authors.lastname: Thomsen
authors.forename: Louise
authors.initials: L
authors.lastname: Bezdjian
authors.forename: Larissa
authors.initials: L
authors.lastname: Rodriguez
authors.forename: Ramona O
authors.initials: RO
authors.lastname: Hopkins
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D003422:Critical Care; D016638:Critical Illness / Q000401:mortality / Q000628:therapy; D004232:Diuretics / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000008:administration & dosage* / Q000009:adverse effects; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D007362:Intensive Care Units; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D061214:Patient Safety; D011446:Prospective Studies; D018570:Risk Assessment; D015996:Survival Rate; D016896:Treatment Outcome; D014883:Water-Electrolyte Imbalance / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D004232:Diuretics; D005665:Furosemide